#USA #Boston #Clinical Trials #Data Management #Veeva DQS

Veeva DQS Enhances Clinical Data Management for Research Institutions

In a groundbreaking move for the clinical research community, Veeva Systems (NYSE: VEEV) has unveiled its latest achievements with the Veeva Data Quality System (DQS). By efficiently aggregating and cleansing data from over a million trial participants across more than 1,000 studies, Veeva DQS is setting a new standard in data management within the biopharmaceutical sector.

Transforming Data with Automation

The Veeva DQS is designed to automate the often cumbersome process of data reconciliation. With over 500,000 automated queries, research sites and sponsors have saved thousands of hours that would otherwise be spent on manual data handling. This is crucial in an era where the volume of data from clinical trials is continuously on the rise.

Ibrahim Kamstrup-Akkaoui, Vice President at Novo, highlights a core challenge faced by the industry: “One of our primary challenges is managing the growing volume of data generated by the increasing number of clinical trials we conduct. Veeva DQS assists in managing, formatting, cleaning, and preparing this data more effectively for submission.”

A Next-Generation Solution

Veeva DQS offers cutting-edge data management capabilities that align with the risk-based monitoring strategies recommended in regulatory guidelines such as ICH E6(R3). Key innovations of the platform include:

• - Rapid Access to High-Quality Data: Veeva DQS streamlines data flows by classifying and visualizing critical data, eliminating the need for manual reconciliation.
• - Risk-Based Quality Management (RBQM): Automatic data exchange between Veeva DQS and Veeva Clinical Trial Management System (CTMS) enhances risk-based monitoring. This system immediately alerts clinical operations teams to significant data changes, such as protocol deviations, allowing for proactive risk management.
• - AI-Enhanced Classification: Integrating artificial intelligence, Veeva DQS accelerates the categorization of study data, providing insights into significance and criticality. This allows the system to generate essential elements such as reports, checklists, and tailored workflows based on user roles.

Pavel Burmenko, head of Veeva DQS strategy, emphasizes that “With the proliferation of data sources and increasingly complex protocols, sponsors and CROs rely on Veeva DQS to automate data flows at scale, regardless of study size. Veeva DQS heralds a new era of data management, introducing an innovative approach to clinical data that coordinates risk-based reviews and elevates data managers to strategic partners.”

Accelerating Study Setup

Recently introduced features like the Veeva Study Builder Agent facilitate faster and more consistent study setups by enabling configurations of Veeva EDC and DQS directly from study protocols. This streamlined approach is a game-changer for clinical research execution.

Biopharmaceutical organizations are invited to discover how Veeva DQS is pioneering innovations in clinical data at the upcoming Veeva RD and Quality Summit set for October 20-21 in Boston, a specialized event for life sciences professionals.

About Veeva Systems

Veeva Systems is dedicated to providing a cloud-based platform specifically designed for life sciences. The company offers applications, agencies, data, and consulting services. With a client roster exceeding 1,500, including major biopharmaceutical firms and emerging biotechs, Veeva continues to prioritize innovation, product excellence, and client success. Learn more at veeva.com/eu.

Forward-Looking Statements

This press release contains forward-looking statements related to Veeva's products and services and expected results or benefits from their use. Actual outcomes may differ substantially based on various factors, including risks and uncertainties outlined in our 10-Q report for the period ending July 31, 2026. These documents are available on the SEC's website.

For press inquiries, contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
[email protected]